Information PortalData PortalKnowledge Portal

Data Matrix

Tools & Workflows

Documentation

1521.58 (Glytoucan)

Id:1b228159-cfb5-5141-9aef-b4de73d3c836

Glytoucan:G00112IO

Results found

Linked to

	Label	Description
	1521.58 has glycosequence GLYGEN.GLYCOSEQUENCE:G20264YL-GLYCOSEQ00088782 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	1521.58 has motif Type 1 LN Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	1521.58 has glycosequence GLYGEN.GLYCOSEQUENCE:G31411IU-GLYCOSEQ00005415 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	1521.58 has glycosequence GLYGEN.GLYCOSEQUENCE:G53286JQ-GLYCOSEQ00188682 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	1521.58 has glycosequence GLYGEN.GLYCOSEQUENCE:G03231HO-GLYCOSEQ00115521 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	1521.58 has glycosequence GLYGEN.GLYCOSEQUENCE:G85310SF-GLYCOSEQ00173984 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	1521.58 has glycosequence GLYGEN.GLYCOSEQUENCE:G00112IO-GLYCOSEQ00185547 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	1521.58 has glycosequence GLYGEN.GLYCOSEQUENCE:G50398UZ-GLYCOSEQ00147302 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	1521.58 has glycosequence GLYGEN.GLYCOSEQUENCE:G16717IV-GLYCOSEQ00118321 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	1521.58 has canonical residue n-glycan a-d-manp 1 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

1521.58 has glycosequence GLYGEN.GLYCOSEQUENCE:G20264YL-GLYCOSEQ00088782 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

1521.58 has motif Type 1 LN

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

1521.58 has glycosequence GLYGEN.GLYCOSEQUENCE:G31411IU-GLYCOSEQ00005415 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

1521.58 has glycosequence GLYGEN.GLYCOSEQUENCE:G53286JQ-GLYCOSEQ00188682 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

1521.58 has glycosequence GLYGEN.GLYCOSEQUENCE:G03231HO-GLYCOSEQ00115521 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

1521.58 has glycosequence GLYGEN.GLYCOSEQUENCE:G85310SF-GLYCOSEQ00173984 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

1521.58 has glycosequence GLYGEN.GLYCOSEQUENCE:G00112IO-GLYCOSEQ00185547 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

1521.58 has glycosequence GLYGEN.GLYCOSEQUENCE:G50398UZ-GLYCOSEQ00147302 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

1521.58 has glycosequence GLYGEN.GLYCOSEQUENCE:G16717IV-GLYCOSEQ00118321 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

1521.58 has canonical residue n-glycan a-d-manp 1

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

DISPLAY PER PAGE

Consortium

Community

Resources

@CFDE Workbench 2025

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2025

This repository is under review for potential modification in compliance with Administration directives.